How often splanchnic vein clots occur in acute pancreatitis and whether they relate to disease severity

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults aged 18–85 diagnosed with acute pancreatitis will be enrolled and their clinical data, laboratory results, and routine imaging studies will be reviewed. Imaging done as part of clinical care (CT, MRI, or ultrasound) will be examined for thrombosis in the splenic, portal, or superior mesenteric veins. The presence of splanchnic vein thrombosis will be compared with established measures of pancreatitis severity and clinical outcomes. Patients with chronic pancreatitis, malignancy, cirrhosis, established portal hypertension, or pregnancy will be excluded.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients aged between 18-85 years of age.
* Diagnosis of AP as per international consensus criteria.

Exclusion Criteria:

* Chronic pancreatitis.
* Established malignancy.
* Cirrhosis of liver or established portal hypertension.
* Pregnancy.

Where it's running

• AIG Hospital
  Hyderabad, Telangana, India Recruiting

Study contacts

• Study coordinator: Sharath Sitaram, MBBS, DNB
• Email: sharath.sitaram@gmail.com
• Phone: 8197016905

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Local complications of acute pancreatitis and postoperative pancreatic fistula: what happens in real life

  This multicenter registry tests how local pancreatic complications are managed in routine care and what outcomes look like over 180 days for adults.

  Recruiting at 12 sites Tokyo University · Ōtsu, Shiga and 11 other locations · NCT07862088

• SGC001 is being tested to help predicted severe acute pancreatitis

  Researchers are testing SGC001 vs placebo in adults with predicted severe acute pancreatitis to see if it is safe and tolerable and to get a sense of any early effects.

  Recruiting Phase 2 Beijing Sungen Biomedical Technology Co., Ltd · Chengdu and 14 other locations · NCT07803965

• Fecal microbiota transplant to prevent infections after late-phase severe acute pancreatitis

  This trial will test whether giving healthy donor gut bacteria (fecal microbiota transplantation) through a feeding tube in the late phase of moderately severe or severe acute pancreatitis can prevent infectious complications.

  Recruiting Changhai Hospital · Fuzhou, Fujian and 11 other locations · NCT07464392

• Fecal microbiota transplant for people with moderate to severe acute pancreatitis

  This trial will test whether a fecal microbiota transplant (FMT) can reduce late complications in adults with moderate to severe acute pancreatitis.

  Recruiting at 2 sites Changhai Hospital · Shanghai, Shanghai Municipality and 1 other locations · NCT07153809

• Blood markers to detect infected pancreatic necrosis

  We will test whether specific blood markers can help predict or diagnose infected pancreatic necrosis in adults with necrotizing pancreatitis.

  Recruiting University of Minnesota · Minneapolis, Minnesota · NCT06899087

• Cryotechnology for removing necrotic pancreatic tissue

  This study is testing a new freezing technique to see if it can help doctors remove dead tissue from the pancreas more effectively in patients with severe pancreatitis.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT06553651

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.